跳至主要内容
临床试验/ACTRN12611000875909
ACTRN12611000875909尚未招募未知

The release of phospholipase A2 inflammatory markers during percutaneous coronary intervention in patients with significant coronary stenosis and their relationship with angiographic, biochemical and epidemiologic factors.

Sir Charles Gairdner Hospital0 个研究点目标入组 250 人开始时间: 2011年8月17日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Patients undergoing elective percutaneous coronary intervention
  • aged 18 to 85 years.
  • For the comparator group patients included will be aged 18 to 85 and undergoing elective coronary angiography only.

排除标准

  • Myocardial ischaemic event <14 days prior to participation
  • Change in HMG-CoA reductase inhibitor(statin) in last 30 days
  • Current acute or chronic inflammatory condition

研究者

相似试验